| AmpliTech Group, Inc. Unit Rights Offering Subscription Period Begins November 11, 2025 |
Globe Newswire |
11/11 |
07:00 |
| ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB) |
Globe Newswire |
11/07 |
11:00 |
| Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide |
Globe Newswire |
11/07 |
08:45 |
| ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025 |
Globe Newswire |
11/07 |
08:00 |
| Chris Van Vliet Joins Cumulus Podcast Network |
Globe Newswire |
11/06 |
14:00 |
| Just One Week Away! HMG Strategy’s Annual New York Global Innovation Summit 2025 unites CIOs, CISOs, and top executives to share insight on IT, AI, cyber security, and innovation |
Globe Newswire |
11/06 |
10:56 |
| New Study Reveals the “New Normal” in Finance: Economic Pressures Push Middle Market Teams Toward Faster Digital and AI |
Globe Newswire |
11/06 |
10:00 |
| KMX Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against CarMax, Inc. |
Globe Newswire |
11/05 |
16:20 |
| NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada |
Globe Newswire |
11/05 |
07:00 |
| ORYZON Announces Positive Clinical Data of Iadademstat at ASH-2025 |
Globe Newswire |
11/04 |
08:00 |
| Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025 |
Globe Newswire |
11/03 |
20:10 |
| Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025 |
Globe Newswire |
11/03 |
20:10 |
| Motorsports Evo 9 RS & AAPEX with New Product Portfolio |
Globe Newswire |
11/03 |
08:30 |
| Corcentric and Avalara Join Forces to Power the Future of Global e-Invoicing Compliance |
Globe Newswire |
10/30 |
09:02 |
| Cumulus Media Reports Operating Results for the Third Quarter 2025 |
Globe Newswire |
10/30 |
08:01 |
| Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025 |
Globe Newswire |
10/29 |
20:00 |
| Westwood One Names Armen Williams Executive Director of 24/7 Sports Programming |
Globe Newswire |
10/29 |
15:00 |
| Corporate Finance Enters a Golden Age as AI and Autonomous Agents Redefine the Office of the CFO |
Globe Newswire |
10/29 |
08:00 |
| Spaarne Gasthuis to Advance its Commitment to Patient Care with Proscia’s Software |
Globe Newswire |
10/27 |
08:00 |
| Auditoria.AI Named to the 2025 CB Insights’ List of the 100 Most Promising Fintech Startups |
Globe Newswire |
10/23 |
08:00 |
| Itron Unveils Gen6™ Network Platform and UtilityIQ® Application Suite, Strengthening Industry Interoperability |
Globe Newswire |
10/22 |
08:45 |
| Cumulus Media and Audacy Announce the Launch of Westwood One Sports 24/7 Programming |
Globe Newswire |
10/21 |
15:00 |
| SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology |
Globe Newswire |
10/21 |
02:00 |
| Cumulus Media Announces Conference Call to Discuss Third Quarter 2025 Operating Results |
Globe Newswire |
10/20 |
16:01 |
| Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL |
Globe Newswire |
10/16 |
15:19 |
